Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (referred to as "Fosun") was established in 1994, August 1998 and October 2012, respectively, in the Shanghai Stock Exchange and Hong Kong Stock Exchange main board listed (stock code: 600196-SH, 02196-HK), is a listed company in a leading position in the Chinese pharmaceutical industry.
1. timely tracking, analysis and judgment of healthcare industry developments, discover new markets, new projects, and actively put forward reasonable proposals.
2. the organization visits, selection, evaluation and project requirements to determine compliance with medical management services Development Committee, on the proposed investment project financial forecasting, risk assessment, to ensure the safety and reliability of the rate of return and investment.
3. for the implementation of investment projects approved by the organization's investment operations, organization of due diligence projects.
4. as the investment...